September 18, 2026
Bonus Content: Paramount Starts Paying $7M a Day for a Deal It Cannot Close
Dear Reader,
A microreactor just generated neutrons at Idaho National Laboratory.
Now the U.S. Army wants the next thing: electrons.
On June 4, Antares Nuclear completed a zero-power criticality test for its Mark-0 demonstrator. According to the Army, it became the first company in the Department of Energy’s Reactor Pilot Program to receive authorization and complete a fueled criticality test.
That isn’t commercial power yet.
And it isn’t the stock I’m writing you about.
But it is a massive signal.
The world’s largest military is no longer treating compact nuclear power like a science-fair project.
The Army says this work supports its Janus Program to deploy advanced microreactors – and says the goal is reliable nuclear power at a military installation in 2028.
Why?
Because mission-critical systems cannot sit around hoping the grid cooperates.
For years, this technology was easy to dismiss.
Now the Army is testing, authorizing, and working toward deployment.
The category is crossing from white papers into physical milestones.
Learn more about the company that I believe could benefit from this shift here.
|
Yours in smart speculation,
Karim Rahemtulla, Head Fundamental Tactician
Monument Traders Alliance
Paramount Starts Paying $7M a Day for a Deal It Cannot Close
Thirteen days from now, Paramount Skydance begins writing a check to Warner Bros. Discovery shareholders for roughly $7 million every single day. The deal is ready to close. PSKY says it has satisfied all closing conditions and received regulatory clearances from 69 jurisdictions. These two lawsuits are the only remaining barrier. And yet the merger cannot move forward, because Judge Araceli Martinez-Olguin is holding it in place pending a trial that does not begin until March 2, 2027.
Why This Trade Stands Out
This is a defined-binary situation with a hard timetable, a compounding financial cost baked into the deal documents, and two publicly traded equities that will price very differently depending on which side wins in court. That combination is precisely where long-dated, defined-risk options can do something that holding shares cannot: carry break risk cheaply while limiting the downside to premium paid.
The Situation Behind the Trade
The Paramount-Warner Bros. Discovery merger’s legal battle with 12 state attorneys general and the Writers Guild of America is headed to a 12-day antitrust trial, with a corresponding ticking-fee exposure that can exceed $1 billion if this stretches deep into 2027. Per the merger agreement, Paramount pays WBD stockholders a per-share ticking fee of $0.00277778 for each day after September 30, 2026 that the merger has not closed, up to a maximum of $0.25 per share per 90-calendar-day period. With roughly 2.5 billion WBD shares outstanding, that arithmetic lands at approximately $7 million per day.
Paramount has said in court filings that by the time trial concludes and the parties submit their final briefs, Paramount will have paid Warner Bros. shareholders an unrecoverable $1.3 billion in ticking fees alone. If the deal ultimately falls through for regulatory reasons, Paramount would also owe a $7 billion regulatory termination fee to Warner Bros. Discovery.
The political pressure around settlement is real but has not produced results. Los Angeles Mayor Karen Bass has called for a settlement, and TheWrap reported that California Attorney General Rob Bonta canceled a planned settlement meeting with Paramount scheduled for Monday.
Technical and Fundamental Alignment
WBD shares have shown increasing implied volatility across multiple sessions this month, appearing on Market Rebellion’s IV-rising lists on September 11 and September 14. That elevated volatility reflects genuine uncertainty, not noise. On WBD, holders collect the ticking fee upon deal close but absorb the full standalone-company risk if the merger is blocked. PSKY carries the liability in either direction: ticking fees if the deal drags, and a $7 billion regulatory termination payment if it collapses. The question is whether current pricing in both PSKY and WBD fully reflects a scenario where this drags into a full antitrust trial.
Paramount has publicly said it has satisfied all closing conditions and received clearances from regulators representing 69 jurisdictions. That context matters: this is not a deal with regulatory risk spread across multiple bodies. It is a single-court, single-judge decision, with trial currently scheduled to end on March 19, 2027.
Options Perspective
The binary resolves somewhere between mid-March and, at the outside, June 1, 2027. Paramount has stipulated it will not close the deal until five days after the merits determination, or June 1, 2027, whichever is earlier. That gives any April 2027 expiration options a clean window around the likely ruling date.
On WBD, a bull call spread targeting deal-close prices offers defined cost with meaningful upside if Martinez-Olguin rules in Paramount’s favor and the merger closes rapidly. The spread structure caps the premium at risk while still capturing the move from current trading levels toward deal value. On PSKY, a bear put spread expresses the break scenario: a ruling against the merger sends PSKY sharply lower as the $7 billion regulatory termination fee crystallizes.
Carrying both sides is expensive. The better-focused approach is to pick the direction where the market appears less compensated and size accordingly. Given that WBD’s ticking-fee income gives it a partial cushion in a prolonged delay, and that PSKY’s balance sheet bears the full brunt of either outcome, PSKY puts likely price the break scenario more cheaply relative to the actual risk.
Risk Management
Settlement before March 2 would collapse the trade in either direction, with the premium the only loss. A ruling that arrives later than April 2027 creates expiration risk for shorter-dated structures, which is why April expiration is the minimum and June expiration is safer. Position size should reflect the binary nature: no single-leg position, and total premium at risk kept to a level that a complete loss of premium would not materially affect the account.
The Beast Verdict
The ticking fee clock starts in 13 days. The trial does not start for 165 days. The ruling could come weeks after that. Holding either stock outright means carrying that entire arc at full equity risk. Options compress that exposure to premium paid, with a clear catalyst window, a hard legal deadline, and a resolution that will move both stocks significantly. A March trial date means Paramount could owe well over $1 billion in ticking fees before the judge ever rules. That pressure does not make the outcome more certain. It makes the options more interesting.
